Clinical Report: Link Between Glucose-to-Potassium Ratio and Outcomes in Critically Ill Patients

Overview

This study investigates the relationship between the glucose-to-potassium ratio (GPR) and all-cause mortality in critically ill patients with sepsis and cancer. Findings suggest that baseline GPR at ICU admission may serve as a prognostic indicator for mortality in this high-risk population.

Background

Sepsis is a significant global health challenge, causing millions of deaths annually, particularly among cancer patients who are at a heightened risk for sepsis. Understanding prognostic factors such as GPR is crucial for improving risk stratification and management in critically ill patients. This study addresses the gap in knowledge regarding the prognostic relevance of GPR in patients with concurrent sepsis and malignancy.

Data Highlights

No numerical data available in the provided material.

Key Findings

• Sepsis affects approximately 49 million individuals globally, with a high mortality rate.
• Cancer patients have a tenfold increased risk of developing sepsis compared to healthy individuals.
• About 30% of cancer-related deaths are attributable to sepsis.
• Glucose-to-potassium ratio (GPR) has been identified as a potential prognostic biomarker in various conditions, though its role in sepsis and malignancy is underexplored.
• The study utilized the MIMIC-IV database, analyzing data from 5,559 adult patients with sepsis and malignancy.
• Identifying risk factors like GPR could lead to improved outcomes through better management strategies in critically ill patients.

Clinical Implications

Clinicians should consider the glucose-to-potassium ratio as a potential prognostic marker for mortality in critically ill patients with sepsis and cancer. Early identification of high-risk patients may facilitate timely interventions and improve patient outcomes.

Conclusion

The findings highlight the importance of GPR as a prognostic tool in critically ill patients with sepsis and malignancy, warranting further research to validate its clinical utility.

References

1. Author(s)/Org, Source, Year -- Title
2. Author(s)/Org, Source, Year -- Title
3. Author(s)/Org, Source, Year -- Title
4. Author(s)/Org, Source, Year -- Title
5. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) - PubMed
6. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 - PMC
7. Associations of serum glucose/potassium ratio with short-term and long-term mortality in sepsis patients: a retrospective cohort study based on the MIMIC-IV database - PMC
8. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) - PubMed
9. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 - PMC
10. Associations of serum glucose/potassium ratio with short-term and long-term mortality in sepsis patients: a retrospective cohort study based on the MIMIC-IV database - PMC